Drugs / Compound danshen dripping pills
Compound danshen dripping pills
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03270787 | Jun → Jul 2016 | acute mountain sickness | Tasly Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02388984 | May 2013 → May 2017 | diabetic retinopathy | Tasly Pharmaceuticals, Inc. | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07041359 | Aug 2025 → Dec 2026 expected | coronary artery disorder | China National Center for Cardiovascular Diseases | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Compound danshen dripping pills | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02388984 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Compound danshen dripping pills is a kind of traditional Chinese medicine(TCM)” NCT02388984 ↗ |
| Route | Oral | “10pills,tid,po” NCT03270787 ↗ |